{"organizations": [], "uuid": "e4e0ef6f43a4a1a090e98da1014f0f7468af9558", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 9, "shares": 9, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.google.com/news?q=migraine&sourceid=navclient-ff&ie=UTF-8&rlz=1B3GGGL_enUS176__218&output=rss", "section_title": "migraine - Google News", "url": "https://www.reuters.com/article/brief-us-fda-approved-aimovig-for-preven/brief-u-s-fda-approved-aimovig-for-preventive-treatment-of-migraine-in-adult-idUSFWN1SO0Z9", "country": "US", "domain_rank": 408, "title": "BRIEF-US FDA Approved Aimovig For Preventive Treatment Of Migraine In Adult - Reuters", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "blogs", "published": "2018-05-18T02:04:00.000+03:00", "replies_count": 0, "uuid": "e4e0ef6f43a4a1a090e98da1014f0f7468af9558"}, "author": "", "url": "https://www.reuters.com/article/brief-us-fda-approved-aimovig-for-preven/brief-u-s-fda-approved-aimovig-for-preventive-treatment-of-migraine-in-adult-idUSFWN1SO0Z9", "ord_in_thread": 0, "title": "BRIEF-US FDA Approved Aimovig For Preventive Treatment Of Migraine In Adult - Reuters", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "fda", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "fda approved aimovig for preventive treatment of migraine in adult", "sentiment": "negative"}, {"name": "raine in adult reuters", "sentiment": "none"}, {"name": "amgen inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 17 (Reuters) -\n* U.S. FDA APPROVES NOVEL PREVENTIVE TREATMENT FOR MIGRAINE\n* U.S. FDA SAYS IT GRANTED THE APPROVAL OF AIMOVIG TO AMGEN INC\n* U.S. FDA APPROVED AIMOVIG (ERENUMAB-AOOE) FOR THE PREVENTIVE TREATMENT OF MIGRAINE IN ADULT Further company coverage:\n ", "external_links": [], "published": "2018-05-18T02:04:00.000+03:00", "crawled": "2018-05-18T03:06:29.010+03:00", "highlightTitle": ""}